Alyeska Investment Group’s Sagimet Biosciences SGMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,192,443
| Closed | -$3.89M | – | 658 |
|
|
2025
Q1 | $3.89M | Sell |
1,192,443
-98,069
| -8% | -$320K | 0.02% | 372 |
|
|
2024
Q4 | $5.81M | Sell |
1,290,512
-87,846
| -6% | -$395K | 0.02% | 390 |
|
|
2024
Q3 | $3.82M | Buy |
1,378,358
+100,000
| +8% | +$277K | 0.02% | 373 |
|
|
2024
Q2 | $4.37M | Buy |
1,278,358
+180,145
| +16% | +$616K | 0.03% | 349 |
|
|
2024
Q1 | $5.95M | Buy |
1,098,213
+611,653
| +126% | +$3.32M | 0.04% | 306 |
|
|
2023
Q4 | $2.64M | Buy |
486,560
+246,531
| +103% | +$1.34M | 0.02% | 337 |
|
|
2023
Q3 | $2.11M | Buy |
+240,029
| New | +$2.11M | 0.01% | 372 |
|